During the past decade, Cardiovascular Institute of Michigan conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Institute of Michigan" are "Bradycardia" (1 trials) and "Heart Failure; With Decompensation" (1 trials). Many other conditions were trialed in "Cardiovascular Institute of Michigan" in a lesser frequency.

Most popular intervention types in "Cardiovascular Institute of Michigan" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "INGEVITY+™ Pace/Sense Lead" (1 trials) and "Wearable Cardioverter Defibrillator (WCD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Institute of Michigan" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Institute of Michigan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cardiovascular Institute of Michigan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Institute of Michigan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".